Abstract
This review reports some recent advances on the use of dendrimer-based systems for cancer therapy. Dendrimers are emerging as promising carriers or stabilizers for drugs and nanoparticles (NPs) due to their highly branched 3-dimensional globular shape, internal hydrophobic cavity and multiple peripheral functional groups. The fabricated nanoplatforms loaded with therapeutic agents such as drugs, siRNAs or NPs can be further modified to have targeting specificity, antifouling properties and good biocompatibility. In particular, recent advances in the surface modifications of dendrimers and the application of dendrimers as versatile platforms for different therapeutic treatments to cancer including chemotherapy, radiotherapy, photothermal therapy, photodynamic therapy, gene therapy, and combination therapy will be introduced in detail.
摘要
本文综述了一些基于树状大分子体系应用于癌症治疗的研究进展. 树状大分子拥有高度支化的三维球状结构、内部疏水空腔以及 多种表面功能基团, 因而可以作为药物和纳米颗粒的载体或者稳定剂. 装载了治疗试剂(如药物、siRNA或者纳米颗粒)的纳米平台可进一 步被修饰而获得靶向特异性、抗污性能和良好的生物相容性. 本文详细介绍了树状大分子表面修饰并作为多功能平台应用于对癌症的不 同治疗手段的进展, 包括: 化疗、放疗、光热治疗、光动力治疗、基因治疗以及联合治疗.
Article PDF
Similar content being viewed by others
References
Tomalia DA, Naylor AM, Goddard WA. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed, 1990, 29: 138–175
Tomalia DA, Baker H, Dewald J, et al. A new class of polymers: starburst-dendritic macromolecules. Polym J, 1985, 17: 117–132
Hawker CJ, Frechet JMJ. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J Am Chem Soc, 1990, 112: 7638–7647
Kawaguchi T, Walker KL, Wilkins CL, et al. Double exponential dendrimer growth. J Am Chem Soc, 1995, 117: 2159–2165
Wooley KL, Hawker CJ, Frechet JMJ. Hyperbranched macromolecules via a novel double-stage convergent growth approach. J Am Chem Soc, 1991, 113: 4252–4261
Wu P, Feldman AK, Nugent AK, et al. Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes. Angew Chem Int Ed, 2004, 43: 3928–3932
Maraval V, Pyzowski J, Caminade AM, et al. “Lego” chemistry for the straightforward synthesis of dendrimers. J Org Chem, 2003, 68: 6043–6046
Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discovery Today, 2001, 6: 427–436
Brothers II HM, Piehler LT, Tomalia DA. Slab-gel and capillary electrophoretic characterization of polyamidoamine dendrimers. J Chromatography A, 1998, 814: 233–246
Hecht S, Fréchet JMJ. Dendritic encapsulation of function: applying nature’s site isolation principle from biomimetics to materials science. Angew Chem Int Ed, 2001, 40: 74–91
Dandliker PJ, Diederich F, Zingg A, et al. Dendrimers with porphyrin cores: Synthetic models for globular heme proteins. Helv Chim Acta, 1997, 80: 1773–1801
Jiang DL, Aida T. A dendritic iron porphyrin as a novel haemoprotein mimic: effects of the dendrimer cage on dioxygenbinding activity. Chem Commun, 1996, 1523
Weyermann P, Gisselbrecht JP, Boudon C, et al. Dendritic iron porphyrins with tethered axial ligands: new model compounds for cytochromes. Angew Chem Int Ed, 1999, 38: 3215–3219
Richter-Egger DL, Tesfai A, Tucker SA. Spectroscopic investigations of poly(propyleneimine)dendrimers using the solvatochromic probe phenol blue and comparisons to poly (amidoamine) dendrimers. Anal Chem, 2001, 73: 5743–5751
Shao N, Su Y, Hu J, et al. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. Int J Nanomed, 2011, 6: 3361–3372
Sadler K, Tam JP. Peptide dendrimers: applications and synthesis. Rev Mol Biotechnol, 2002, 90: 195–229
Ionov M, Wróbel D, Gardikis K, et al. Effect of phosphorus dendrimers on DMPC lipid membranes. Chem Phys Lipids, 2012, 165: 408–413
Tomalia DA, Esfand R. Dendrons, dendrimers and dendrigrafts. Chem Ind, 1997, 416–420
Buhleier E, Wehner W, Vögtle F. "Cascade"-and "nonskid-chainlike" syntheses of molecular cavity topologies. Synthesis, 1978, 1978: 155–158
Ly TU, Tran NQ, Hoang TKD, et al. Pegylated dendrimer and its effect in fluorouracil loading and release for enhancing antitumor activity. J Biomed Nanotechnol, 2013, 9: 213–220
Kesharwani P, Tekade RK, Jain NK. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer. Biomaterials, 2014, 35: 5539–5548
Roberts BP, Scanlon MJ, Krippner GY, et al. Molecular dynamics of poly(L-lysine) dendrimers with naphthalene disulfonate caps. Macromolecules, 2009, 42: 2775–2783
Ohsaki M, Okuda T, Wada A, et al. In vitro gene transfection using dendritic poly(L-lysine). Bioconjugate Chem, 2002, 13: 510–517
Kratz F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J Control Release, 2008, 132: 171–183
Fanali G, di Masi A, Trezza V, et al. Human serum albumin: From bench to bedside. Mol Aspects Med, 2012, 33: 209–290
Maraval V, Caminade AM, Majoral JP, et al. Dendrimer design: how to circumvent the dilemma of a reduction of steps or an increase of function multiplicity? Angew Chem Int Ed, 2003, 42: 1822–1826
Gurdag S, Khandare J, Stapels S, et al. Activity of dendrimer −methotrexate conjugates on methotrexate-sensitive and-resistant cell lines. Bioconjugate Chem, 2006, 17: 275–283
Patri AK, Myc A, Beals J, et al. Synthesis and in vitro testing of J591 antibody−dendrimer conjugates for targeted prostate cancer therapy. Bioconjugate Chem, 2004, 15: 1174–1181
Svenson S, Tomalia DA. Dendrimers in biomedical applications —reflections on the field. Adv Drug Deliver Rev, 2012, 64: 102–115
Tajarobi F, El-Sayed M, Rege BD, et al. Transport of poly amidoamine dendrimers across Madin–Darby canine kidney cells. Int J Pharm, 2001, 215: 263–267
Toscano MD, Müller MM, Hilvert D. Enhancing activity and controlling stereoselectivity in a designed PLP-dependent aldolase. Angew Chem Int Ed, 2007, 46: 4468–4470
Khandare JJ, Jayant S, Singh A, et al. Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjugate Chem, 2006, 17: 1464–1472
Kono K, Liu M, Fréchet JMJ. Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chem, 1999, 10: 1115–1121
Morgan MT, Carnahan MA, Immoos CE, et al. Dendritic molecular capsules for hydrophobic compounds. J Am Chem Soc, 2003, 125: 15485–15489
Ziemba B, Janaszewska A, Ciepluch K, et al. In vivo toxicity of poly(propyleneimine) dendrimers. J Biomed Mater Res, 2011, 99A: 261–268
Cheng Y, Zhao L, Li Y, et al. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem Soc Rev, 2011, 40: 2673–2703
Zhu J, Shi X. Dendrimer-based nanodevices for targeted drug delivery applications. J Mater Chem B, 2013, 1: 4199–4211
Shen M, Shi X. Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale, 2010, 2: 1596–1610
Choi JS, Nam K, Park JY, et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release, 2004, 99: 445–456
Madaan K, Kumar S, Poonia N, et al. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioall Sci, 2014, 6: 139–150
Kesharwani P, Iyer AK. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discovery Today, 2015, 20: 536–547
Peng C, Zheng L, Chen Q, et al. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials, 2012, 33: 1107–1119
Thakur S, Tekade RK, Kesharwani P, et al. The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers. J Nanopart Res, 2013, 15: 1625
Jia L, Xu JP, Wang H, et al. Polyamidoamine dendrimers surfaceengineered with biomimetic phosphorylcholine as potential drug delivery carriers. Colloids Surfs B-Biointerfaces, 2011, 84: 49–54
Wang L, Wang Z, Ma G, et al. Reducing the cytotoxity of poly (amidoamine) dendrimers by modification of a single layer of carboxybetaine. Langmuir, 2013, 29: 8914–8921
Xiong Z, Wang Y, Zhu J, et al. Dendrimers meet zwitterions: development of a unique antifouling nanoplatform for enhanced blood pool, lymph node and tumor CT imaging. Nanoscale, 2017, 9: 12295–12301
Kolhatkar RB, Kitchens KM, Swaan PW, et al. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem, 2007, 18: 2054–2060
Zhang M, Guo R, Kéri M, et al. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers. J Phys Chem B, 2014, 118: 1696–1706
Chen Q, Wang H, Liu H, et al. Multifunctional dendrimer-entrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors. Anal Chem, 2015, 87: 3949–3956
Li Q, Gu W, Liu K, et al. RGD conjugated, Cy5.5 labeled polyamidoamine dendrimers for targeted near-infrared fluorescence imaging of esophageal squamous cell carcinoma. RSC Adv, 2016, 6: 74560–74566
Wei P, Chen J, Hu Y, et al. Dendrimer-stabilized gold nanostars as a multifunctional theranostic nanoplatform for CT imaging, photothermal therapy, and gene silencing of tumors. Adv Healthcare Mater, 2016, 5: 3203–3213
Kong L, Alves CS, Hou W, et al. RGD peptide-modified dendrimer-entrapped gold nanoparticles enable highly efficient and specific gene delivery to stem cells. ACS Appl Mater Interfaces, 2015, 7: 4833–4843
Zhu J, Fu F, Xiong Z, et al. Dendrimer-entrapped gold nanoparticles modified with RGD peptide and alpha-tocopheryl succinate enable targeted theranostics of cancer cells. Colloids Surfs B-Biointerfaces, 2015, 133: 36–42
Lee S, Jung S, Koo H, et al. Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo. Biomaterials, 2017, 148: 1–15
Fu F, Wu Y, Zhu J, et al. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer. ACS Appl Mater Interfaces, 2014, 6: 16416–16425
Hashemi M, Ayatollahi S, Parhiz H, et al. PEGylation of polypropylenimine dendrimer with alkylcarboxylate chain linkage to improve DNA delivery and cytotoxicity. Appl Biochem Biotechnol, 2015, 177: 1–17
Franiak-Pietryga I, Ostrowska K, Maciejewski H, et al. PPI-G4 glycodendrimers upregulate TRAIL-induced apoptosis in chronic lymphocytic leukemia cells. Macromol Biosci, 2017, 17: 1600169
Klementieva O, Aso E, Filippini D, et al. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer’s disease. Biomacromolecules, 2013, 14: 3570–3580
Xiong Z, Wang Y, Zhu J, et al. Gd-chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications. Biomater Sci, 2016, 4: 1622–1629
Tietze S, Schau I, Michen S, et al. A poly(propyleneimine) dendrimer-based polyplex-system for single-chain antibody-mediated targeted delivery and cellular uptake of siRNA. Small, 2017, 13: 1700072
Kesharwani P, Tekade RK, Jain NK. Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations. Pharm Res, 2015, 32: 1438–1450
Hashemi M, Tabatabai SM, Parhiz H, et al. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers. Mater Sci Eng-C, 2016, 61: 791–800
Park JW, Mok H, Park TG. Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. J Control Release, 2010, 142: 238–244
Jain K, Gupta U, Jain NK. Dendronized nanoconjugates of lysine and folate for treatment of cancer. Eur J Pharm BioPharm, 2014, 87: 500–509
Hayder M, Poupot M, Baron M, et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Translational Med, 2011, 3: 81ra35
Shcharbin D, Dzmitruk V, Shakhbazau A, et al. Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier. Pharmaceutics, 2011, 3: 458–473
Dobrovolskaia MA, Aggarwal P, Hall JB, et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharmaceutics, 2008, 5: 487–495
Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol, 2007, 2: 751–760
Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol, 2007, 2: 469–478
Wang P, Yang J, Zhou B, et al. Antifouling manganese oxide nanoparticles: synthesis, characterization, and applications for enhanced MR imaging of tumors. ACS Appl Mater Interfaces, 2017, 9: 47–53
Ma D, Chen J, Luo Y, et al. Zwitterion-coated ultrasmall iron oxide nanoparticles for enhanced T1-weighted magnetic resonance imaging applications. J Mater Chem B, 2017, 5: 7267–7273
Cao Y, He Y, Liu H, et al. Targeted CT imaging of human hepatocellular carcinoma using low-generation dendrimer-entrapped gold nanoparticles modified with lactobionic acid. J Mater Chem B, 2015, 3: 286–295
Oh MH, Lee N, Kim H, et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc, 2011, 133: 5508–5515
Appelhans D, Klajnert-Maculewicz B, Janaszewska A, et al. Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications. Chem Soc Rev, 2015, 44: 3968–3996
Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliver Rev, 2011, 63: 131–135
Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliver Rev, 2011, 63: 161–169
Sisson AL, Steinhilber D, Rossow T, et al. Biocompatible functionalized polyglycerol microgels with cell penetrating properties. Angew Chem Int Ed, 2009, 48: 7540–7545
Sharma AK, Gothwal A, Kesharwani P, et al. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. Drug Discovery Today, 2017, 22: 314–326
Kesharwani P, Tekade RK, Jain NK. Formulation development and in vitro–in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector. Nanomedicine, 2014, 9: 2291–2308
Campbell IG, Jones TA, Foulkes WD, et al. Polate-binding protein is a marker for ovarian-cancer. Cancer Res, 1991, 51: 5329–5338
Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant-cell lines and tissues. Cancer Res, 1992, 52: 3396–3401
Qiao Z, Shi X. Dendrimer-based molecular imaging contrast agents. Prog Polymer Sci, 2015, 44: 1–27
Fan Y, Sun W, Shi X. Design and biomedical applications of poly (amidoamine)-dendrimer-based hybrid nanoarchitectures. Small Methods, 2017, 1: 1700224
Tomalia DA, Hall M, Hedstrand DM. Starburst dendrimers. III. The importance of branch junction symmetry in the development of topological shell molecules. J Am Chem Soc, 1987, 109: 1601–1603
Tomalia DA, Fréchet JMJ. Discovery of dendrimers and dendritic polymers: A brief historical perspective. J Polym Sci A Polym Chem, 2002, 40: 2719–2728
Li X, Takashima M, Yuba E, et al. PEGylated PAMAM dendrimer–doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy. Biomaterials, 2014, 35: 6576–6584
Shi X, Lee I, Chen X, et al. Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter, 2010, 6: 2539–2545
Zhang C, Pan D, Li J, et al. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy. Acta Biomater, 2017, 55: 153–162
Zhu J, Zheng L, Wen S, et al. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials, 2014, 35: 7635–7646
Golshan M, Salami-Kalajahi M, Roghani-Mamaqani H, et al. Poly (propylene imine) dendrimer-grafted nanocrystalline cellulose: Doxorubicin loading and release behavior. Polymer, 2017, 117: 287–294
Zhu J, Zhao L, Cheng Y, et al. Radionuclide 131I-labeled multifunctional dendrimers for targeted SPECT imaging and radiotherapy of tumors. Nanoscale, 2015, 7: 18169–18178
Cheng Y, Zhu J, Zhao L, et al. 131I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. Nanomedicine, 2016, 11: 1253–1266
Hector M, Guillermina F, Flor de MR, et al. Lu-177-dendrimer conjugated to folate and bombesin with gold nanoparticles in the dendritic cavity: A potential theranostic radiopharmaceutical. J Nanomater, 2016, 1039258
Mendoza-Nava H, Ferro-Flores G, Ramírez FM, et al. Fluorescent, plasmonic, and radiotherapeutic properties of the 177Lu–dendrimer-AuNP–folate–bombesin nanoprobe located inside cancer cells. Mol Imag, 2017, 16: 153601211770476
Li X, Takeda K, Yuba E, et al. Preparation of PEG-modified PAMAM dendrimers having a gold nanorod core and their application to photothermal therapy. J Mater Chem B, 2014, 2: 4167–4176
Zan M, Li J, Huang M, et al. Near-infrared light-triggered drug release nanogels for combined photothermal-chemotherapy of cancer. Biomater Sci, 2015, 3: 1147–1156
Kong L, Xing L, Zhou B, et al. Dendrimer-modified MoS2 nanoflakes as a platform for combinational gene silencing and photothermal therapy of tumors. ACS Appl Mater Interfaces, 2017, 9: 15995–16005
Zhou Z, Wang Y, Yan Y, et al. Dendrimer-templated ultrasmall and multifunctional photothermal agents for efficient tumor ablation. ACS Nano, 2016, 10: 4863–4872
Bastien E, Schneider R, Hackbarth S, et al. PAMAM G4.5-chlorin-e6 dendrimeric nanoparticles for enhanced photodynamic effects. Photochem Photobiol Sci, 2015, 14: 2203–2212
Taratula O, Schumann C, Naleway MA, et al. A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy. Mol Pharmaceutics, 2013, 10: 3946–3958
Dabrzalska M, Zablocka M, Mignani S, et al. Phosphorus dendrimers and photodynamic therapy. Spectroscopic studies on two dendrimer-photosensitizer complexes: Cationic phosphorus dendrimer with rose bengal and anionic phosphorus dendrimer with methylene blue. Int J Pharm, 2015, 492: 266–274
Dabrzalska M, Janaszewska A, Zablocka M, et al. Cationic phosphorus dendrimer enhances photodynamic activity of rose bengal against basal cell carcinoma cell lines. Mol Pharmaceutics, 2017, 14: 1821–1830
Chang H, Zhang Y, Li L, et al. Efficient delivery of small interfering RNA into cancer cells using dodecylated dendrimers. J Mater Chem B, 2015, 3: 8197–8202
Shan Y, Luo T, Peng C, et al. Gene delivery using dendrimerentrapped gold nanoparticles as nonviral vectors. Biomaterials, 2012, 33: 3025–3035
Qiu J, Kong L, Cao X, et al. Dendrimer-entrapped gold nanoparticles modified with β-cyclodextrin for enhanced gene delivery applications. RSC Adv, 2016, 6: 25633–25640
Hou W, Wen S, Guo R, et al. Partially acetylated dendrimerentrapped gold nanoparticles with reduced cytotoxicity for gene delivery applications. J Nanosci Nanotechnol, 2015, 15: 4094–4105
Hou W, Wei P, Kong L, et al. Partially PEGylated dendrimerentrapped gold nanoparticles: a promising nanoplatform for highly efficient DNA and siRNA delivery. J Mater Chem B, 2016, 4: 2933–2943
Ionov M, Lazniewska J, Dzmitruk V, et al. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction. Int J Pharm, 2015, 485: 261–269
Liu H, Wang Y, Wang M, et al. Fluorinated poly(propylenimine) dendrimers as gene vectors. Biomaterials, 2014, 35: 5407–5413
Guo R, Shi X. Dendrimers in cancer therapeutics and diagnosis. Curr Drug Metab, 2012, 13: 1097–1109
Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications. Adv Drug Deliver Rev, 2012, 64: 866–884
D’Emanuele A, Attwood D. Dendrimer–drug interactions. Adv Drug Deliver Rev, 2005, 57: 2147–2162
Liu X, Liu C, Chen C, et al. Targeted delivery of dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system. NanoMed-Nanotechnol Biol Med, 2014, 10: 1627–1636
Pooja D, Kulhari H, Singh MK, et al. Dendrimer–TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes. Colloids Surfs B-Biointerfaces, 2014, 121: 461–468
D'Huyvetter M, Xavier C, Caveliers V, et al. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer. Expert Opin Drug Deliver, 2014, 11: 1939–1954
Das T, Pillai MRA. Options to meet the future global demand of radionuclides for radionuclide therapy. Nucl Med Biol, 2013, 40: 23–32
Kassis AI, Adelstein SJ. Radiobiologic principles in radionuclide therapy. J Nucl Med, 2005, 46: 4S–12S
Chen L, Luo Q, Shen Y, et al. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med, 2008, 49: 1952–1957
Banerjee S, Pillai MRA, Knapp FFR. Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications. Chem Rev, 2015, 115: 2934–2974
Ferro-Flores G, Ocampo-García B, Santos-Cuevas C, et al. Theranostic radiopharmaceuticals based on gold nanoparticles labeled with 177Lu and conjugated to peptides. Curr Radiopharm, 2015, 8: 150–159
Ait-Mohand S, Fournier P, Dumulon-Perreault V, et al. Evaluation of 64Cu-labeled bifunctional chelate–bombesin conjugates. Bioconjugate Chem, 2011, 22: 1729–1735
Chung US, Kim JH, Kim B, et al. Dendrimer porphyrin-coated gold nanoshells for the synergistic combination of photodynamic and photothermal therapy. Chem Commun, 2016, 52: 1258–1261
Zhang Y, Pang L, Ma C, et al. Small molecule-initiated lightactivated semiconducting polymer dots: an integrated nanoplatform for targeted photodynamic therapy and imaging of cancer cells. Anal Chem, 2014, 86: 3092–3099
Mohammadpour R, Safarian S, Buckway B, et al. Comparative endocytosis mechanisms and anticancer effect of HPMA copolymer-and PAMAM dendrimer-MTCP conjugates for photodynamic therapy. Macromol Biosci, 2017, 17: 1600333
Tao X, Yang YJ, Liu S, et al. Poly(amidoamine) dendrimer-grafted porous hollow silica nanoparticles for enhanced intracellular photodynamic therapy. Acta Biomater, 2013, 9: 6431–6438
Hutnick MA, Ahsanuddin S, Guan L, et al. PEGylated dendrimers as drug delivery vehicles for the photosensitizer silicon phthalocyanine Pc 4 for candidal infections. Biomacromolecules, 2017, 18: 379–385
Rodriguez L, Vallecorsa P, Battah S, et al. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease. Photochem Photobiol Sci, 2015, 14: 1617–1627
Yang J, Zhang Q, Chang H, et al. Surface-engineered dendrimers in gene delivery. Chem Rev, 2015, 115: 5274–5300
Wang S, Wang F, Zhang Q, et al. A core–shell structured polyplex for efficient and non-toxic gene delivery. J Mater Chem B, 2017, 5: 5101–5108
Guan L, Huang S, Chen Z, et al. Low cytotoxicity fluorescent PAMAM dendrimer as gene carriers for monitoring the delivery of siRNA. J Nanopart Res, 2015, 17: 385
Shen W, Liu H, Ling-Hu Y, et al. Enhanced siRNA delivery of a cyclododecylated dendrimer compared to its linear derivative. J Mater Chem B, 2016, 4: 5654–5658
Liu C, Liu X, Rocchi P, et al. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA Delivery in vitro and in vivo. Bioconjugate Chem, 2014, 25: 521–532
Wang M, Liu H, Li L, et al. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nat Commun, 2014, 5: 3053
Kala S, Mak ASC, Liu X, et al. Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer. J Med Chem, 2014, 57: 2634–2642
Chen H, Jia H, Tham HP, et al. Theranostic prodrug vesicles for imaging guided codelivery of camptothecin and siRNA in synergetic cancer therapy. ACS Appl Mater Interfaces, 2017, 9: 23536–23543
You JO, Guo P, Auguste DT. A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release. Angew Chem Int Ed, 2013, 52: 4141–4146
Ren F, Bhana S, Norman DD, et al. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjugate Chem, 2013, 24: 376–386
Song J, Pu L, Zhou J, et al. Biodegradable theranostic plasmonic vesicles of amphiphilic gold nanorods. ACS Nano, 2013, 7: 9947–9960
Song X, Liang C, Gong H, et al. Photosensitizer-conjugated albumin− polypyrrole nanoparticles for imaging-guided in vivo photodynamic/photothermal therapy. Small, 2015, 11: 3932–3941
Taratula O, Schumann C, Duong T, et al. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy. Nanoscale, 2015, 7: 3888–3902
Yang Z, Gao D, Cao Z, et al. Drug and gene co-delivery systems for cancer treatment. Biomater Sci, 2015, 3: 1035–1049
Zhang XD, Wu D, Shen X, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials, 2012, 33: 6408–6419
Liang G, Jin X, Zhang S, et al. RGD peptide-modified fluorescent gold nanoclusters as highly efficient tumor-targeted radiotherapy sensitizers. Biomaterials, 2017, 144: 95–104
Wen S, Zhao Q, An X, et al. Multifunctional pegylated multiwalled carbon nanotubes for enhanced blood pool and tumor MR imaging. Adv Healthcare Mater, 2014, 3: 1568–1577
Mustafa R, Luo Y, Wu Y, et al. Dendrimer-functionalized laponite nanodisks as a platform for anticancer drug delivery. Nanomaterials, 2015, 5: 1716–1731
Acknowledgements
This research is financially supported by the Fundamental Research Funds for the Central Universities (for Shi X, Xiong Z, and Shen M), the Science and Technology Commission of Shanghai Municipality (15520711400 and 17540712000), and the National Natural Science Foundation of China (81761148028 and 21773026).
Author information
Authors and Affiliations
Corresponding author
Additional information
Zhijuan Xiong received her Bachelor’s degree in biological engineering from Donghua University in 2014. Now she is a PhD student at Donghua University under the supervision of Prof. Xiangyang Shi. Her current research interests include the design of dendrimer-based systems for cancer diagnosis and therapy.
Mingwu Shen received her PhD degree in 2001 from Tsinghua University. Afterwards, she went to the University of Michigan, Ann Arbor as a visiting scholar and a research area specialist intermediate. She joined Donghua University in 2008 as an associate professor, and was promoted to be a full professor of biomedical engineering in 2018. Her current research interests include nanoparticle-based platforms for medical imaging and therapy applications, and the development of nanofiber-based technology for biomedical and environmental applications.
Xiangyang Shi obtained his PhD degree in 1998 from the Chinese Academy of Sciences. From 2002 to 2008, he was appointed as a research fellow, research associate II, research investigator, and research assistant professor in Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor. In September 2008, he joined Donghua University as a full professor. His current research interests are focused on the development of organic/inorganic hybrid nanoplatforms and microfluidic platforms for sensing, imaging, and theranostic applications, in particular for precision cancer imaging and therapy.
Rights and permissions
About this article
Cite this article
Xiong, Z., Shen, M. & Shi, X. Dendrimer-based strategies for cancer therapy: Recent advances and future perspectives. Sci. China Mater. 61, 1387–1403 (2018). https://doi.org/10.1007/s40843-018-9271-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40843-018-9271-4